B-Lipo — Class II drug recall D-0424-2015
Terminated recall by Bethel Nutritional Consulting, Inc, reported 2015-04-01, distributed nationwide. Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight los
| Recall number | D-0424-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bethel Nutritional Consulting, Inc, New York, NY, United States |
| Recall initiated | 2014-12-19 |
| Classified | 2015-03-24 |
| Reported by FDA | 2015-04-01 |
| Terminated | 2018-06-04 |
| Distributed | Nationwide (US) |
| Reason classes | unapproved product |
| Lot numbers | 20213 |
| Expiration dates | 2016-12-22 |
Product
B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.
Reason for recall
Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0424-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.